Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of AIM ImmunoTech Inc (AMEX: AIM) was $0.22 for the day, up 9.60% from the previous closing price of $0.20. In other words, the price has increased by $9.60 from its previous closing price. On the day, 0.53 million shares were traded. AIM stock price reached its highest trading level at $0.2175 during the session, while it also had its lowest trading level at $0.2022.
Ratios:
Our analysis of AIM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.75 and its Current Ratio is at 0.75. In the meantime, Its Debt-to-Equity ratio is 1.17 whereas as Long-Term Debt/Eq ratio is at 0.20.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 19 ’24 when MITCHELL WILLIAM M sold 4,580 shares for $0.19 per share. The transaction valued at 884 led to the insider holds 118,549 shares of the business.
Equels Thomas K bought 22,727 shares of AIM for $4,682 on Dec 18 ’24. The CEO & President now owns 1,680,695 shares after completing the transaction at $0.21 per share. On Dec 02 ’24, another insider, APPELROUTH STEWART, who serves as the Director of the company, bought 11,112 shares for $0.21 each. As a result, the insider paid 2,356 and bolstered with 355,509 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AIM now has a Market Capitalization of 13840108 and an Enterprise Value of 6039479. For the stock, the TTM Price-to-Sale (P/S) ratio is 72.85 while its Price-to-Book (P/B) ratio in mrq is 4.37. Its current Enterprise Value per Revenue stands at 30.047 whereas that against EBITDA is -0.193.
Stock Price History:
Over the past 52 weeks, AIM has reached a high of $0.62, while it has fallen to a 52-week low of $0.16. The 50-Day Moving Average of the stock is -3.75%, while the 200-Day Moving Average is calculated to be -34.92%.
Shares Statistics:
AIM traded an average of 470.74K shares per day over the past three months and 603310 shares per day over the past ten days. A total of 58.67M shares are outstanding, with a floating share count of 56.31M. Insiders hold about 11.72% of the company’s shares, while institutions hold 14.13% stake in the company. Shares short for AIM as of 1730332800 were 491374 with a Short Ratio of 1.09, compared to 1727654400 on 590329. Therefore, it implies a Short% of Shares Outstanding of 491374 and a Short% of Float of 0.8500000000000001.
